DRUGS MADE IN AMERICA ACQUISITION II CORP.: cashflow_financing
| Value | {"amount": 275130, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2024-08-23 – 2024-09-30 |
| Status | current |
| Entity | DRUGS MADE IN AMERICA ACQUISITION II CORP. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0ae2332e-cdd5-4233-84dd-730f32310e8c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-112095Retrieved: 2026-08-19T19:07:31.882959+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0002040475/cashflow-financing/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0ae2332e-cdd5-4233-84dd-730f32310e8c
History
- no predecessors — first report